Subcongenic analysis of the Idd13 locus in NOD/Lt mice: Evidence for several susceptibility genes including a possible diabetogenic role for β2- microglobulin

Journal of Immunology

Volumn 160, Issue 3, 1998, Pages 1472-1478

  Serreze, David V ^a   Bridgett, Margot ^a   Chapman, Harold D ^a   Chen, Emmie ^a   Richard, Scott D ^a   Leiter, Edward H ^a  

^a JACKSON LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN; GENE PRODUCT; MONOCLONAL ANTIBODY;

ALLELE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; AUTOIMMUNITY; CHROMOSOME 2; CONTROLLED STUDY; GENE LOCUS; GENETIC SUSCEPTIBILITY; HORMONE RESISTANCE; INSULIN DEPENDENT DIABETES MELLITUS; INSULITIS; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; T LYMPHOCYTE;

ALLELES; ANIMALS; BETA 2-MICROGLOBULIN; DIABETES MELLITUS, TYPE 1; DIMERIZATION; DISEASE SUSCEPTIBILITY; FEMALE; GENETIC MARKERS; H-2 ANTIGENS; INTERFERON TYPE II; ISOMERISM; MACROPHAGES; MALE; MICE; MICE, INBRED NOD; PROTEIN CONFORMATION; SPECIES SPECIFICITY; T-LYMPHOCYTE SUBSETS;

EID: 0031914643     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Serreze, D. V., and E. H. Leiter. 1994. Genetic and pathogenic basis of autoimmune diabetes in NOD mice. Curr. Opin. Immunol. 6:900.
2. Wicker, L. S., J. A. Todd, and L. B. Peterson. 1995. Genetic control of autoimmune diabetes in the NOD mouse. Annu. Rev. Immunol. 13:179.
3. Acha-Orbea, H., and H. O. McDevitt. 1987. The first external domain of the nonobese diabetic mouse class II I-Aβ chain is unique. Proc. Natl. Acad. Sci. USA 84:2435.
4. nod to the development of insulitis in non-obese diabetic mice. Nature 345:722.
5. k transgenic mice. Nature 345:724.
6. Lund, T., L. O'Reilly, P. Hutchings, O. Kanagawa, E. Simpson, R. Gravely, P. Chandler, J. Dyson, J. K. Picard, A. Edwards, D. Kioussis, and A. Cooke. 1990. Prevention of insulin-dependent diabetes mellitus in non-obese diabetic mice by transgenes encoding modified I-A β-chain or normal I-E α-chain. Nature 345:727.
7. d transgene prevents diabetes in nonobese diabetic mice by inducing regulatory T cells. Proc. Natl. Acad. Sci. USA 90:9566.
8. Nerup, J., T. Mandrup-Poulsen, S. Helqvist, H. U. Andersen, F. Pociot, J. I. Reimers, B. G. Cuartero, A. E. Karlsen, U. Bjerre, and T. Lorenzen. 1994. On the pathogenesis of IDDM. Diabetologia 37:(Suppl 2):82.
9. Katz, J., C. Benoist, and D. Mathis. 1993. Major histocompatibility complex class I molecules are required for the development of insulitis in non-obese diabetic mice. Eur. J. Immunol 23:3358.
10. Wicker, L. S., E. H. Leiter, J. A. Todd, R. J. Renjilian, E. Peterson, P. A. Fischer, P. L. Podolin, M. Zijlstra, R. Jaenisch, and L. B. Peterson. 1994. β2-microglobulin-deficient NOD mice do not develop insulitis or diabetes. Diabetes 43:500.
11. null mice are diabetes and insulitis resistant. Diabetes 43:505.
12. Sumida, T., M. Furukawa, A. Sakamoto, T. Namekawa, T. Maeda, M. Zijlstra, I. Iwamoto, T. Koike, S. Yoshida, H. Tomioka, and M. Taniguchi. 1994. Prevention of insulitis and diabetes in beta(2)-microglobulin-deficient non-obese diabetic mice. Int. Immunol. 6:1445.
13. Serreze, D. V., H. D. Chapman, D. S. Varnum, I. Gerling, E. H. Leiter, and L. D. Shultz. 1997. Initiation of autoimmune diabetes in NOD/Lt mice is MHC class I-dependent. J. Immunol. 158:3978.
14. Ikegami, H., S. Makino, E. Yamato, Y. Kawaguchi, H. Ueda, T. Sakamoto, K. Takekawa, and T. Ogihara. 1995. Identification of a new susceptibility locus for insulin-dependent diabetes mellitus by ancestral haplotype congenic mapping. J. Clin. Invest. 96:1936.
15. Fennessy M., K. Metcalfe, G. A. Hitman, M. Niven, P. A. Biro, J. Tuomilehto, and E. Tuomilehto-Wolf. 1994. A gene in the HLA class I region contributes to susceptibility to IDDM in the Finnish population. Diabetologia 37:937.
16. Demaine, A. G., M. L. Hibberd, D. Mangles, and B. A. Millward. 1995. A new marker in the HLA class I region is associated with the age at onset of IDDM. Diabetologia 38:622.
17. Prochazka, M., D. V. Serreze, W. N. Frankel, and E. H. Leiter. 1992. NOR/Lt mice: MHC-matched diabetes-resistant control strain for NOD mice. Diabetes 41:98.
18. Serreze, D. V., M. Prochazka, P. C. Reifsnyder, M. Bridgett, and E. H. Leiter. 1994. Use of recombinant congenic and congenic strains of NOD mice to identify a new insulin-dependent diabetes resistance gene. J. Exp. Med. 180:1553.
19. Naggert, J. K., M. L. Mu, W. F. Frankel, and B. Paigen. 1995. Genomic analysis of the C57BL/Ks mouse strain. Mammal. Genome 6:131.
20. Serreze, D. V., H. R. Gaskins, and E. H. Leiter. 1993. Defects in the differentiation and function of antigen presenting cells in NOD/Lt mice. J. Immunol. 150:2534.
21. + cytotoxic T lymphocyte responses in autoimmune diabetes-prone NOD mice. Diabetes 45:902.
22. McAleer, M. A., P. C. Reifsnyder, S. M. Palmer, M. Prochazka, J. M. Love, J. B. Copeman, E. E. Powell, N. R. Rodrigues, J.-B. Prins, D. V. Serreze, N. H. DeLarto, L. S. Wicker, L. B. Peterson, N. J. Schork, J. A. Todd, and E. H. Leiter. 1995. Crosses of NOD mice with the related NON strain: a polygenic threshold model for Type I diabetes. Diabetes 44:1186.
23. Serreze, D. V., and E. H. Leiter. 1988. Defective activation of T suppressor cell function in nonobese diabetic mice: potential relation to cytokine deficiencies. J. Immunol. 140:3801.
24. Serreze, D. V., and E. H. Leiter. 1991. Development of diabetogenic T cells from NOD/Lt marrow is blocked when an allo-H-2 haplotype is expressed on cells of hematopoietic origin, but not on thymic epithelium. J. Immunol. 147:1222-1229.
25. Serreze, D. V., H. D. Chapman, D. S. Varnum, M. S. Hanson, P. C. Reifsnyder, S. D. Richard, S. A. Fleming, E. H. Leiter, and L. D. Shultz. 1996. B lymphocytes are essential for the initiation of T cell-mediated autoimmune diabetes: analysis of a new "speed congenic" stock of NOD. Igμnull mice. J. Exp. Med. 184:2049.
26. Ferrier, P., J. C. Fontecilla-Camps, D. Bucchini, D. H. Caillol, B. R. Jordon, and F. A. Lemonnier. 1985. Altered stucture of HLA class I heavy chains associated with mouse beta-2 microglobulin. Immunogenetics 21:321.
27. d with human beta-2 microglobulin induces localized conformational changes in the alpha-1 and -2 superdomain. Immunogenetics 30:361.
28. 2-microglobulin induces a conformational change in MHC class I H chain that occurs intracellularly and is maintained at the cell surface. J. Immunol. 153:3533.
29. Perarnau, B., C.-A. Siegrist, A. Gillet, C. Vincent, S. Kimura, and F. A. Lemonnier. 1990. β2-Microglobulin restriction of antigen presentation. Nature 346:751.
30. Serreze, D. V., and E. H. Leiter. 1996. Insulin-dependent diabetes mellitus (IDDM) in NOD mice and BB rats: origins in hematopoietic stem cell defects and implications for therapy. In Lessons from Animal Diabetes V. E. Shafrir, eds. Smith-Gordon, London. p59.
31. Jacob, C. O., S. Aiso, S. A. Michie, H. O. McDevitt, and H. Acha-Orbea. 1990. Prevention of diabetes in nonobese diabetic mice by tumor necrosis factor (TNF); similarities between TNF-α and interleukin 1. Proc. Natl. Acad. Sci. USA 87:968.
32. Podolin, P. L., P. Denny, C. J. Lord, N. J. Hill, J. A. Todd, L. B. Peterson, L. S. Wicker, and P. A. Lyons. 1997. Congenic mapping of the insulin-dependent diabetes (Idd) gene, Idd10, localizes two genes mediating the Idd10 effect, and eliminates the candidate Fcgr1. J. Immunol. 159:1835.
33. 1 mice. Diabetes 37:252.
34. 1 mice with bone marrow cells from NOD mice. J. Exp. Med. 167:1801.
35. 1 bone marrow chimeras. Diabetologia 33:84.
36. Serreze, D. V., J. W. Gaedeke, and E. H. Leiter. 1993. Hematopoietic stem cell defects underlying abnormal macrophage development and maturation in NOD/Lt mice: defective regulation of cytokine receptors and protein kinase C. Proc. Natl. Acad. Sci. USA 90:9625.
37. Mathieu, C., K. Castells, R. Bouillon, and M. Waer. 1997. Protection against autoimmune diabetes in mixed bone marrow chimeras. J. Immunol. 158:1453.
38. Faustman, D., X. Li, H. Y. Lin, Y. Fu, G. Eisenbarth, J. Avruch, and J. Guo. 1991. Linkage of faulty major histocompatability complex class 1 to autoimmune diabetes. Science 254:1756.
39. Li, F., J. Guo, Y. Fu, G. Yan, and D. Faustman. 1994. Abnormal class I assembly and peptide presentation in the nonobese diabetic mouse. Proc. Natl. Acad. Sci. USA 91:11128.
40. Huang, R., J. Guo, X. Li, and D. L. Faustman. 1995. Elimination of self-peptide major histocompatability class I reactivity in NOD and β2-microglobulin-negative mice. Diabetes 44:1114.
41. Reich, E.-P., H. von Grafenstein, A. Barlow, K. E. Swenson, K. Williams, and C. A. Janeway. 1994. Self peptides isolated from MHC glycoproteins of non-obese diabetic mice. J. Immunol. 152:2279.
42. Wicker, L. S., P. L. Podolin, P. Fischer, A. Sirotina, R. C. Boltz, and L. B. Peterson. 1992. Expression of intra-MHC transporter (Ham) genes and class I antigens in diabetes susceptible NOD mice. Science 256:1828.
43. + T cell development in the nonobese nondiabetic mouse. J. Immunol. 151:5338.
44. b on splenic leukocytes are normal in NOD mice. Diabetes 44:572.
45. Hao, W., P. Gladstone, S. Engardt, C. Greenbaum, and J. P. Palmer. 1996. Major histocompatability complex class I molecule expression is normal on peripheral blood lymphocytes from patients with insulin-dependent diabetes. J. Clin. Invest. 98:1613.
46. g7 (NOD/Lt) haplotype translocate similar sets of peptides. Proc. Natl. Acad. Sci. USA 91:13004.
47. Parnes, J. R., and J. G. Seidman. 1982. Structure of wild-type and mutant mouse β2-microglobulin genes. Cell 29:661.